INDRAMEDCO · Healthcare · Medical Care Facilities
Composite scorecard: 48/100 — Quality 71 · Valuation 45 · Momentum 0
| Share price | ₹374.55 |
| Market cap | ₹3,491 Cr |
| P/E ratio | 19.0 |
| P/B ratio | 4.7 |
| ROCE | 30.7% |
| Dividend yield | 1.19% |
| Book value | ₹80.78 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹1,483 Cr | ₹184 Cr | 15.1% |
| 2025 | ₹1,356 Cr | ₹161 Cr | 14.7% |
| 2024 | ₹1,204 Cr | ₹124 Cr | 13.6% |
| 2023 | ₹1,065 Cr | ₹86 Cr | 10.5% |
| 2022 | — | — | — |
Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as